Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.
作者信息
Abdallah Maya, McEllistrim Cian, Kumar Anita J, Loh Kah Poh
机构信息
Divisions of Geriatrics, Hematology and Oncology, Boston University School of Medicine, Boston, USA.
Department of Haematology, Sligo University Hospital, Sligo, Ireland.
出版信息
J Geriatr Oncol. 2021 Jun;12(5):860-862. doi: 10.1016/j.jgo.2021.02.010. Epub 2021 Feb 20.
Abstract
摘要
相似文献
1
Perspectives on Geriatric Hematology Research presented at the 2020 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.在2020年美国血液学会年会上发表的老年血液学研究观点：青年国际老年肿瘤学会报告。
J Geriatr Oncol. 2021 Jun;12(5):860-862. doi: 10.1016/j.jgo.2021.02.010. Epub 2021 Feb 20.
2
Perspectives on geriatric oncology research presented at the 2023 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology report.在2023年美国血液学会年会上发表的老年肿瘤学研究观点：国际老年肿瘤学会青年报告
J Geriatr Oncol. 2024 Jun;15(5):101762. doi: 10.1016/j.jgo.2024.101762. Epub 2024 Apr 11.
3
Geriatric hematology research at the 2019 American Society of Hematology annual meeting: Young International Society of geriatric oncology perspective paper.2019年美国血液学会年会上的老年血液学研究：国际老年肿瘤学会青年视角论文
J Geriatr Oncol. 2020 May;11(4):735-739. doi: 10.1016/j.jgo.2020.01.010. Epub 2020 Jan 31.
4
Geriatric Hematology Research presented at the 2018 American Society of Hematology Annual Meeting: Young International Society of Geriatric Oncology Perspective Paper.在2018年美国血液学会年会上发表的老年血液学研究：国际老年肿瘤学会青年视角论文。
J Geriatr Oncol. 2019 Mar;10(2):186-191. doi: 10.1016/j.jgo.2019.01.006. Epub 2019 Jan 18.
5
"Celebrating Resilience": A review of abstracts on functional resilience at the International Society of Geriatric Oncology 2022 annual meeting.“庆祝恢复力”：国际老年肿瘤学会2022年年会关于功能恢复力的摘要综述
J Geriatr Oncol. 2023 Sep;14(7):101587. doi: 10.1016/j.jgo.2023.101587. Epub 2023 Jul 15.
6
Perspectives on geriatric oncology research presented at the 2019 International Society of Geriatric Oncology Annual Meeting: Young International Society of Geriatric Oncology report.在2019年国际老年肿瘤学会年会上发表的老年肿瘤学研究观点：国际老年肿瘤学会青年报告
J Geriatr Oncol. 2020 Apr;11(3):549-552. doi: 10.1016/j.jgo.2020.01.003. Epub 2020 Jan 15.
7
Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young International Society of Geriatric Oncology Report of the 2020 American Society of Clinical Oncology (ASCO) annual meeting.老年评估融入常规肿瘤护理及老年肿瘤学进展：国际老年肿瘤学会关于2020年美国临床肿瘤学会（ASCO）年会的一份新报告
J Geriatr Oncol. 2020 Nov;11(8):1324-1328. doi: 10.1016/j.jgo.2020.07.009. Epub 2020 Jul 27.
8
Geriatric oncology research at the 2019 American Geriatrics Society (AGS) annual meeting: Joint perspectives from the Young International Society of Geriatric Oncology (SIOG) and AGS Cancer and Aging Special Interest Group.2019年美国老年医学会（AGS）年会中的老年肿瘤学研究：国际老年肿瘤学青年学会（SIOG）与AGS癌症与衰老特别兴趣小组的联合观点
J Geriatr Oncol. 2019 Nov;10(6):994-997. doi: 10.1016/j.jgo.2019.06.008. Epub 2019 Jul 1.
9
Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.血液学-肿瘤学专科住院医师在老年医学和老年肿瘤学方面的培训：美国临床肿瘤学会发起的一项全国性调查结果
J Oncol Pract. 2017 Nov;13(11):e900-e908. doi: 10.1200/JOP.2017.022111. Epub 2017 Aug 24.
10
Perspectives on Geriatric Oncology Research presented at the 2018 American Society of Clinical Oncology Annual Meeting.在2018年美国临床肿瘤学会年会上发表的老年肿瘤学研究观点。
J Geriatr Oncol. 2018 Sep;9(5):419-422. doi: 10.1016/j.jgo.2018.06.013. Epub 2018 Jul 10.
本文引用的文献
1
Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.急性髓系白血病的治疗决策：一项对老年患者和社区肿瘤医生的定性研究。
Leuk Lymphoma. 2021 Feb;62(2):387-398. doi: 10.1080/10428194.2020.1832662. Epub 2020 Oct 11.
2
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.有可测量残留病与急性髓系白血病患者生存结局的关联：系统评价和荟萃分析。
JAMA Oncol. 2020 Dec 1;6(12):1890-1899. doi: 10.1001/jamaoncol.2020.4600.
3
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.阿扎胞苷和维奈托克治疗未经治急性髓系白血病。
N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.
4
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.维奈托克联合 LDAC 方案用于不适合强化化疗的新诊断 AML：一项 3 期随机安慰剂对照试验。
Blood. 2020 Jun 11;135(24):2137-2145. doi: 10.1182/blood.2020004856.
5
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma.维布妥昔单抗在经典型霍奇金淋巴瘤中不断演变的作用
Blood Lymphat Cancer. 2019 Dec 9;9:63-71. doi: 10.2147/BLCTT.S231821. eCollection 2019.
6
Derivation and Validation of a Generalizable Preoperative Frailty Index Using Population-based Health Administrative Data.基于人群健康管理数据的可推广术前衰弱指数的推导和验证。
Ann Surg. 2019 Jul;270(1):102-108. doi: 10.1097/SLA.0000000000002769.
7
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.FIRST 试验中多发性骨髓瘤一线治疗的生存结局最终分析。
Blood. 2018 Jan 18;131(3):301-310. doi: 10.1182/blood-2017-07-795047. Epub 2017 Nov 17.
Zotero 插件